Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Small-Cap Index Fund

T. Rowe Price Small-Cap Index Fund (TRCSX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000051327

Share classes and tickers: TRCSX (C000161838), TRSYX (C000161837), TRZIX (C000219329)

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,691 with, 73 against, 0 abstentions (not counted as with management); 4 items carried no recommendation; 12 split votes are in neither count. Shareholder proposals: 20 FOR, 24 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)87.2%15,22493.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a62.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 101 items (2.9% of the 3,487 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Alliance Laundry Holdings Inc.2026-06-11To elect Michael D. Schoeb, Phyllis A. Knight and Robert L. Verigan as Class I directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert L. VeriganWithholdFOR — 7 of 7 T. Rowe Price fundsAgainst—
IRadimed Corporation2026-06-23Election of Directors: Joe KianiWithholdFOR — 7 of 7 T. Rowe Price fundsAgainstElected, 98.9% support
Equity Bancshares, Inc.2026-04-21Election of Directors: Gregory L. GaeddertForAGAINST — 7 of 7 T. Rowe Price fundsForElected, 66.8% support
CECO Environmental Corp.2026-05-27CECO Director Election Proposal. To vote on a proposal to elect the eight directors named in the accompanying joint proxy statement/prospectus to serve until the next annual meeting of stockholders and until their successors have been duly elected and qualified (the "CECO director election proposal"AgainstFOR — 7 of 7 T. Rowe Price fundsAgainstElected, 99.7% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: L. R. WeirichForWITHHOLD — 6 of 6 T. Rowe Price fundsForElected, 95.6% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: R. W. CardinForWITHHOLD — 6 of 6 T. Rowe Price fundsForElected, 91.0% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: S. C. DuheForWITHHOLD — 6 of 6 T. Rowe Price fundsForElected, 95.4% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: T. S. Hawkins, Jr.ForWITHHOLD — 6 of 6 T. Rowe Price fundsForElected, 90.7% support
BKV Corp.2026-06-11Election of Class II Directors: Akaraphong DayanandaWithholdFOR — 6 of 6 T. Rowe Price fundsAgainstElected, 86.7% support
BKV Corp.2026-06-11Election of Class II Directors: Thiti MekavichaiWithholdFOR — 6 of 6 T. Rowe Price fundsAgainstElected, 86.7% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Bernadette AndriettiAgainstFOR — 6 of 6 T. Rowe Price fundsAgainstElected, 94.9% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Louis SilverAgainstFOR — 6 of 6 T. Rowe Price fundsAgainstElected, 95.8% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Maria MarcedAgainstFOR — 6 of 6 T. Rowe Price fundsAgainstElected, 95.7% support
Immunovant, Inc.2025-08-27To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesWithholdFOR — 8 of 9 T. Rowe Price fundsAgainstElected, 89.5% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: Robyn JonesForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 77.3% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: William Wade, Jr.ForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 77.3% support
Middlesex Water Company2026-05-19Election of Directors: Vaughn L. McKoyForWITHHOLD — 7 of 8 T. Rowe Price fundsForPassed (calculated), 79.7% support
Vishay Precision Group, Inc.2026-05-19Election of Directors: Nava Swersky SoferForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Saul ReibsteinForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Sejal Shah GulatiForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Texas Capital Bancshares, Inc.2026-04-21To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. LongForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 85.7% support
GPGI, Inc.2026-06-11Election of Directors: Brian F. HughesWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
GPGI, Inc.2026-06-11Election of Directors: Joseph J. DeAngeloWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 99.8% support
GPGI, Inc.2026-06-11Election of Directors: Mark R. JamesWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 92.2% support
OceanFirst Financial Corp.2026-04-02A proposal to approve the issuance of (a) OceanFirst common stock to holders of Flushing common stock (the "Flushing stockholders") pursuant to the merger agreement and (b) OceanFirst common stock, a new class of non-voting, common-equivalent stock of OceanFirst ("OceanFirst NVCE stock") and a warraForAGAINST — 6 of 7 T. Rowe Price fundsForApproved, 94.3% support
Show all 101
Items 26 to 101.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Equity Bancshares, Inc.2026-04-21Advisory vote to approve the compensation paid to the named executive officers of the Company.AgainstFOR — 8 of 10 T. Rowe Price fundsAgainstApproved, 65.5% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 88.4% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John F. McGovern, three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 86.2% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 82.9% support
HarborOne Bancorp, Inc.2025-08-20A proposal to approve, on an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of HarborOne in connection with the merger (the "Merger-Related Compensation Proposal"); andAgainstFOR — 8 of 10 T. Rowe Price fundsAgainst—
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 15 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares without Rights of Pre-Emption.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainstApproved, 81.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainst—
Adaptive Biotechnologies Corporation2026-06-05To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MDForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Jody A. MarkopoulosWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: John W. KuoWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Kenneth C. BockhorstWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Lawrence D. KingsleyWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Robert A. CascellaWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Sheila RegeWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Steven W. EtzelWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. LanceWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. DisbrowWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Che-Wei LinForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Robert (Bob) FlanaganForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Miami International Holdings, Inc.2026-06-16The election of the 15 director nominees: Talal Jassim Al-BaharWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 75.7% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. AugsburgerWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 97.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. SuggsWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.5% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 83.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott WelchWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. KitsonWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. BrownWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 94.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. ClevelandWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.5% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Chris BruzzoForWITHHOLD — 7 of 9 T. Rowe Price fundsForElected, 77.8% support
Root, Inc.2026-06-03To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence HilsheimerForAGAINST — 7 of 9 T. Rowe Price fundsForElected, 92.8% support
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the 2025 Compensation Report.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Re-election of Ali Behbahani, M.D.ForAGAINST — 5 of 6 T. Rowe Price fundsFor—
CRISPR Therapeutics AG2026-06-04Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D.ForAGAINST — 5 of 6 T. Rowe Price fundsFor—
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 71.3% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 83.0% support
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.AgainstFOR — 6 of 8 T. Rowe Price fundsAgainstApproved, 69.4% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardAgainstFOR — 6 of 8 T. Rowe Price fundsAgainst—
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Brent TurnerWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 96.9% support
PBF Energy Inc.2026-04-28Election of Directors: Spencer AbrahamAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.6% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Marshall LuxAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 98.0% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 80.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 96.9% support
Miami International Holdings, Inc.2026-06-16The approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 73.9% support
Flagstar Bank, N.A.2026-06-09An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement.AgainstFOR — 8 of 13 T. Rowe Price fundsAgainstPassed (calculated), 81.2% support
Advanced Energy Industries, Inc.2026-05-07Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; andAgainstFOR — 6 of 9 T. Rowe Price fundsAgainstApproved, 78.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.3% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstApproved, 84.3% support
Marqeta, Inc.2026-06-10To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.ForAGAINST — 7 of 11 T. Rowe Price fundsForPassed (calculated), 78.7% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 87.8% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 8 of 14 T. Rowe Price fundsForPassed (calculated), 78.5% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerForWITHHOLD — 8 of 14 T. Rowe Price fundsFor—
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinAgainstFOR — 7 of 12 T. Rowe Price fundsAgainstElected, 93.9% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 7 of 12 T. Rowe Price fundsAgainstApproved, 68.0% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 60.9% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support
NovoCure Limited2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.AgainstFOR — 2 of 3 T. Rowe Price fundsAgainstApproved, 50.3% support

Download all 101 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.0% of this fund’s 15,764 such votes could be given a sector; the other 1,570 (10.0%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,179170.5%
Consumer Discretionary2,755240.9%
Health Care2,435110.5%
Industrials1,58350.3%
Technology1,43240.3%
Real Estate88610.1%
Energy61500.0%
Utilities38400.0%
Consumer Staples26551.9%
Basic Materials24500.0%
Miscellaneous21000.0%
Telecommunications20510.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,66933
Audit-related1,8583
Say-on-Pay1,8564
Compensation6462
Corporate Governance45717
Capital Structure2263
Extraordinary Transactions2034
Shareholder Rights and Defenses491
Other Social Issues30
Diversity, Equity, and Inclusion22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
agilon health, inc.March 17, 2026$5M20
Bloom Energy CorporationMay 21, 2026$5M80
Guardant Health, Inc.June 17, 2026$2M50
Glaukos CorporationMay 28, 2026$2M40
BridgeBio Pharma, Inc.June 22, 2026$1M70
The Ensign Group, Inc.May 13, 2026$1M60
American Healthcare REIT, Inc.June 24, 2026$1M110
Semtech CorporationJune 4, 2026$1M120

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalAgainstFor
May 12, 2026Group 1 Automotive, Inc.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalAgainstFor
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
June 3, 2026Resideo Technologies, Inc.Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

15,976 ballot items at 2,078 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Small-Cap Index Fund (TRCSX) voted at 2,078 shareholder meetings of 1,959 companies, on 15,976 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 73 times. Its most frequent area of disagreement was director elections (33 of its votes against management). It voted on 56 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (87.2% against 93.7%). It voted differently from most T. Rowe Price funds on 101 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.